Starting Monday, Korean Air will implement a new policy requiring passengers to step on a scale before boarding their flights. The law, which applies to all Korean flag carriers, requires airlines to weigh passengers and their carry-on luggage every five years in the interest of flight safety. However, the announcement of this policy has received …
Several startups specializing in AI-powered drug discovery have recently secured substantial funding. Causaly, BenchSci, Iktos, TandemAI, and Protai have all closed significant funding rounds this year. Joining this list is Genesis Therapeutics, which recently announced the completion of a $200 million Series B funding round. This round brings the total funding for the Burlingame, California-based …
According to a recent poll, Americans have identified opioids and obesity as the primary threats to public health, ranking COVID-19 lower on the list. The Axios-Ipsos poll revealed that 26 percent of Americans consider opioids and fentanyl to be the greatest public health threat, closely followed by 23 percent who view obesity as a significant …
An analysis by KFF reveals that drugs like Ozempic, Wegovy, and Mounjaro are priced significantly higher in the U.S. compared to other affluent nations. In some countries, the list price is only 10% of what it is in the U.S. KFF’s analysis found that the list price for a one-month supply of Ozempic, which is …
Slimfast has experienced a decline in sales due to the rising popularity of weight loss drugs like Ozempic. Data from Glanbia, the owner of Slimfast, shows that consumption of the company’s meal replacement shakes in the US dropped by 33% between May and July. This decline can be attributed to the increasing demand for drugs …
Novo Nordisk, a Danish pharmaceutical company, has announced its acquisition of Inversago Pharma, a private obesity drug manufacturer, for a potential sum of $1.08 billion. This move aims to expand Novo Nordisk’s portfolio of weight loss treatments, following the success of its Wegovy and Ozempic injections. The final price of the deal will be determined …
Insurers use BMI as a factor in determining life insurance premiums, with higher thresholds for younger individuals. According to Mr. Lakey, insurers assume that younger individuals have a higher risk of becoming morbidly obese in the future, resulting in higher premiums. For policyholders aged 17 to 30, HSBC charges extra fees of up to 150% …
A collection of injector pens for Saxenda, a weight loss drug, is featured in a photo illustration in Chicago, Illinois, US, on March 31, 2023. A recent clinical trial has shown that Novo Nordisk’s obesity drug Wegovy can reduce the risk of serious heart problems by 20%, which is a significant finding that could increase …
Wegovy, an obesity drug, has announced that it reduces the risk of serious heart problems by 20%. This groundbreaking result highlights the potential for obesity drugs to not only aid in weight loss but also target cardiovascular health. The manufacturer, Novo Nordisk, has released the top-line results and will present the detailed findings from the …
Sopa Images | Lightrocket | Getty Images On Tuesday, Eli Lilly, a leading pharmaceutical company, raised its full-year guidance as second-quarter profit surged 85% compared to the same period last year. The increase in profit was driven by strong sales from the company’s drug pipeline. Eli Lilly now expects full-year revenue between $33.4 billion to …